Adaptive Nanomedicinal Compositions for Breast Cancer Treatment in Specialized Environments
Legal Citation
Summary of the Inventive Concept
A novel approach to breast cancer treatment using nanomedicinal compositions tailored for specific, high-stakes environments, such as high-security facilities, disaster relief scenarios, extreme weather conditions, remote rural areas, and space exploration settings.
Background and Problem Solved
The original patent disclosed a nanomedicinal composition for breast cancer treatment, but its limitations in terms of transport, storage, and administration in unique operational environments prompted the development of specialized variations to address these gaps.
Detailed Description of the Inventive Concept
The new inventive concept adapts the original nanomedicinal composition to meet the demands of specific, high-stakes environments. For instance, the composition is designed for secure transport and storage in high-security facilities, or for use in portable, emergency medical kits in disaster relief scenarios. In extreme weather conditions, the composition is engineered to withstand extreme temperatures and humidity. For remote, rural areas, the composition is optimized for transport via unmanned aerial vehicles (UAVs). In space exploration settings, the composition is tailored for use in microgravity environments. These adaptations enable effective breast cancer treatment in environments where traditional compositions may be impractical or ineffective.
Novelty and Inventive Step
The new claims introduce novel adaptations of the original nanomedicinal composition, including secure transport and storage designs, portable emergency medical kits, extreme weather-resistant formulations, UAV-transportable compositions, and microgravity-compatible designs. These adaptations constitute a non-obvious, inventive step beyond the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include adaptations for other high-stakes environments, such as military operations or search and rescue missions. Variations could also include different nanocarrier materials, magnetic ferrite particle sizes, or pharmaceutical agent mixtures tailored to specific environments or applications.
Potential Commercial Applications and Market
The adaptive nanomedicinal compositions have significant commercial potential in industries such as healthcare, pharmaceuticals, and biotechnology, particularly in specialized markets catering to high-security facilities, disaster relief organizations, and space exploration agencies.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/6923 |
| A | A61 | A61K31/138 |
| A | A61 | A61K31/282 |
| A | A61 | A61K33/243 |
| A | A61 | A61K47/10 |
| A | A61 | A61K2121/00 |
| A | A61 | A61K2800/47 |
| B | B82 | B82Y5/00 |
| B | B82 | B82Y25/00 |
| B | B82 | B82Y30/00 |
| B | B82 | B82Y40/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Nanomedicine, pharmaceutical compositions, cancer treatment technologies, with expertise in nanocarrier design, magnetic nanoparticle engineering, and targeted drug delivery systems
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in materials science, chemical engineering, or pharmaceutical sciences, possessing knowledge of nanoparticle synthesis, drug encapsulation techniques, and medical device adaptation for specialized environments
Obviousness Rationale
A person having ordinary skill would recognize that the fundamental nanomedicinal composition from US 11857639 can be readily adapted to different environmental contexts by applying standard engineering principles of material modification and contextual optimization. The core technological elements remain consistent across the variations, with modifications representing predictable design adaptations for specific use cases. The PTD demonstrates routine engineering problem-solving by extending the original nanomedicinal composition's applicability through targeted environmental adjustments.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,639 |
|---|---|
| Title | Method for treating breast cancer |
| Assignee(s) | Imam Abdulrahman Bin Faisal University |